KLRS
Kalaris Therapeutics
KLRS
KLRS
71 hedge funds and large institutions have $33.9M invested in Kalaris Therapeutics in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
36% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 25
Holders
71
Holding in Top 10
–
Calls
$202K
Puts
$2K
Top Buyers
| 1 | +$4.05M | |
| 2 | +$325K | |
| 3 | +$291K | |
| 4 |
Millennium Management
New York
|
+$255K |
| 5 |
Two Sigma Advisers
New York
|
+$243K |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$1.95M | |
| 3 | -$691K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$453K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$297K |